Literature DB >> 18217955

Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains.

Vincent Flacher1, Patrice Douillard, Smina Aït-Yahia, Patrizia Stoitzner, Valérie Clair-Moninot, Nikolaus Romani, Sem Saeland.   

Abstract

Langerin/CD207 is expressed by a subset of dendritic cells (DC), the epithelial Langerhans cells. However, langerin is also detected among lymphoid tissue DC. Here, we describe striking differences in langerin-expressing cells between inbred mouse strains. While langerin+ cells are observed in comparable numbers and with comparable phenotypes in the epidermis, two distinct DC subsets bear langerin in peripheral, skin-draining lymph nodes of BALB/c mice (CD11c(high) CD8alpha(high) and CD11c(low) CD8alpha(low)), whereas only the latter subset is present in C57BL/6 mice. The CD11c(high) subset is detected in mesenteric lymph nodes and spleen of BALB/c mice, but is virtually absent from C57BL/6 mice. Similar differences are observed in other mouse strains. CD11c(low) langerin+ cells represent skin-derived Langerhans cells, as demonstrated by their high expression of DEC-205/CD205, maturation markers, and recruitment to skin-draining lymph nodes upon imiquimod-induced inflammation. It will be of interest to determine the role of lymphoid tissue-resident compared to skin-derived langerin+ DC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18217955      PMCID: PMC2433329          DOI: 10.1111/j.1365-2567.2007.02785.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

1.  Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules.

Authors:  J Valladeau; O Ravel; C Dezutter-Dambuyant; K Moore; M Kleijmeer; Y Liu; V Duvert-Frances; C Vincent; D Schmitt; J Davoust; C Caux; S Lebecque; S Saeland
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  In vivo-matured Langerhans cells continue to take up and process native proteins unlike in vitro-matured counterparts.

Authors:  C Ruedl; P Koebel; K Karjalainen
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

3.  Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.

Authors:  J L Pooley; W R Heath; K Shortman
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

4.  Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells.

Authors:  Hiroshi Mitsui; Takahiro Watanabe; Hidehisa Saeki; Katsunori Mori; Hideki Fujita; Yayoi Tada; Akihiko Asahina; Koichiro Nakamura; Kunihiko Tamaki
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

5.  The dendritic cell populations of mouse lymph nodes.

Authors:  S Henri; D Vremec; A Kamath; J Waithman; S Williams; C Benoist; K Burnham; S Saeland; E Handman; K Shortman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

6.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

7.  Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.

Authors:  H Suzuki; B Wang; G M Shivji; P Toto; P Amerio; M A Tomai; R L Miller; D N Sauder
Journal:  J Invest Dermatol       Date:  2000-01       Impact factor: 8.551

8.  Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody.

Authors:  Carine Asselin-Paturel; Géraldine Brizard; Jean-Jacques Pin; Francine Brière; Giorgio Trinchieri
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

9.  Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization.

Authors:  P R Bergstresser; G B Toews; J W Streilein
Journal:  J Invest Dermatol       Date:  1980-07       Impact factor: 8.551

10.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  26 in total

Review 1.  In vivo function of Langerhans cells and dermal dendritic cells.

Authors:  Daniel H Kaplan
Journal:  Trends Immunol       Date:  2010-10-28       Impact factor: 16.687

Review 2.  Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues.

Authors:  D Sichien; B N Lambrecht; M Guilliams; C L Scott
Journal:  Mucosal Immunol       Date:  2017-02-15       Impact factor: 7.313

Review 3.  The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Authors:  Miriam Merad; Priyanka Sathe; Julie Helft; Jennifer Miller; Arthur Mortha
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

4.  Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.

Authors:  Vincent Flacher; Christoph H Tripp; Bernhard Haid; Adrien Kissenpfennig; Bernard Malissen; Patrizia Stoitzner; Juliana Idoyaga; Nikolaus Romani
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

5.  Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.

Authors:  Juliana Idoyaga; Ashira Lubkin; Christopher Fiorese; Mireille H Lahoud; Irina Caminschi; Yaoxing Huang; Anthony Rodriguez; Björn E Clausen; Chae Gyu Park; Christine Trumpfheller; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

6.  Histone deacetylases inhibitor Trichostatin A ameliorates DNFB-induced allergic contact dermatitis and reduces epidermal Langerhans cells in mice.

Authors:  Yu-Ling Shi; Jun Gu; Jang-June Park; Jun-Yang Park; Ying-Ping Xu; Fu-Shin Yu; Li Zhou; Qing-Sheng Mi
Journal:  J Dermatol Sci       Date:  2012-09-07       Impact factor: 4.563

Review 7.  The evolving function of Langerhans cells in adaptive skin immunity.

Authors:  Botond Z Igyarto; Daniel H Kaplan
Journal:  Immunol Cell Biol       Date:  2010-03-16       Impact factor: 5.126

Review 8.  Building on dendritic cell subsets to improve cancer vaccines.

Authors:  Karolina Palucka; Hideki Ueno; Gerard Zurawski; Joseph Fay; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2010-03-11       Impact factor: 7.486

9.  Acute ablation of Langerhans cells enhances skin immune responses.

Authors:  Aleh Bobr; Irlanda Olvera-Gomez; Botond Z Igyarto; Krystal M Haley; Kristin A Hogquist; Daniel H Kaplan
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

10.  Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.

Authors:  Andrew M Platt; Joseph M Rutkowski; Catherine Martel; Emma L Kuan; Stoyan Ivanov; Melody A Swartz; Gwendalyn J Randolph
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.